Jee-Woong Lim

USPTO Granted Patents = 8 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Gyeonggi-do, KR (2005 - 2024)
Seongnam-Si, KR (2022 - 2024)

Company Filing History:

Cj Cheiljedang Corporation

patents

Years Active: 2005-2024

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12049444 - Monomethyl fumarate precursor drug compounds and pharmaceutical compositions thereof (2024-07-30),

2. 12011443 - Pharmaceutical composition for preventing or treating nonalcoholic steatohepatitis (2024-06-18),

3. 11485716 - Compounds useful for treatment or prevention of muscular dystrophy and derivatives for treatment, amelioration or prevention of muscular dystrophy in medicinal use thereof (2022-11-01),

4. 11427547 - Edaravone prodrug compound and pharmaceutical use thereof in treatment or alleviation of neurodegenerative or motor neuron disease (2022-08-30),

5. 7435819 - 4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-C] pyridine-3-thione compounds (2008-10-14),

6. 7169929 - Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor (2007-01-30),

7. 7135572 - Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor (2006-11-14),

8. 6946558 - Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor (2005-09-20),

Title: Inventor Spotlight: Jee-Woong Lim

Introduction

Jee-Woong Lim, a distinguished inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of 8 patents to his name, Lim has been at the forefront of developing novel compounds aimed at treating various medical conditions.

Latest Patents

Among his notable recent patents are the "Monomethyl fumarate precursor drug compounds and pharmaceutical compositions thereof," which offers innovative compounds capable of producing monomethyl fumarate for medical applications. These compounds hold promise for treating immune system abnormalities, neurodegeneration, and inflammatory diseases. Another key invention is the "Pharmaceutical composition for preventing or treating nonalcoholic steatohepatitis," focused on a specific compound's efficacy against non-alcoholic steatohepatitis (NASH) and hepatic fibrosis.

Career Highlights

Jee-Woong Lim's career includes significant roles at prominent companies like CJ Corporation and J2H Biotech Inc. His work has not only advanced pharmaceutical research but has also led to practical applications that benefit patients globally.

Collaborations

Throughout his career, Lim has collaborated with esteemed colleagues such as Hyung-chul Ryu and Il-Hwan Cho, enhancing his research efforts and contributing to the collective knowledge in the field of pharmaceutical sciences.

Conclusion

Jee-Woong Lim continues to be a pivotal figure in pharmaceutical innovation, committed to developing effective treatments for complex health issues. His inventions are a testament to his dedication to improving medical solutions and the enhancement of patient care.

This text is generated by artificial intelligence and may not be accurate.